Avidity Biosciences
RNA
$14.02
Share price
-0.92%
Change (1 day)
-46.51%
Change (1 year)
Categories
Market capitalization of Avidity Biosciences (RNA)
Market cap: $0.69 Billion
As of June 2022 Avidity Biosciences has a market cap of $0.69 Billion. This makes Avidity Biosciences the world's 4655th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Avidity Biosciences from 2020 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.70 B | -36.52% |
| 2021 | $1.11 B | 16.4% |
| 2020 | $0.95 B |
End of Day market cap according to different sources
On Jun 28th, 2022 the market cap of Avidity Biosciences was reported to be:
$0.70 Billion
$0.70 Billion
$0.66 Billion
$0.70 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $286.38 B | 40,947.35% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $111.28 B | 15,851.14% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $6.65 B | 853.54% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.86 B | 311.20% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $2.37 B | 240.02% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.01 B | -98.51% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 1,466.84% | 🇺🇸 USA |